C3;129S7-Hprt1tm2Brd/Biat

Status

Available to order

EMMA IDEM:06049
Citation informationRRID:IMSR_EM:06049 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameC3;129S7-Hprt1tm2Brd/Biat
Alternative nameHPRT1-Myo7a-EGFP-betaActin-SV40pA-BAC transgene
Strain typeTargeted Mutant Strains : Other targeted
Allele/Transgene symbolHprt1tm2Brd
Gene/Transgene symbolHprt1

Information from provider

ProviderHaydn Prosser
Provider affiliationWellcome Trust Sanger Institute
Genetic informationThe transgene contains EGFP-beta-actin-SV40pA in place of the myosin 7a translation initiation codon within the BAC clone RPCI23-138G2. The modified BAC was site specifically integrated at the modified Hprt1 locus by cre recombinase-mediated cassette exchange (RMCE).
Phenotypic informationThe mouse strain expresses EGFP-beta actin in mouse inner ear hair cells and can be used to fluorescently label stereocilia. In heterozygous females the labelling is mosaic.
Breeding historyThe transgenic was created in AB1 derived 129 ES cells. Chimaeras produced from the ES cells were mated with C3H strain. Strain was then maintained by intercrossing F1 and subsequent generations without further backcrossing.
References
  • Mosaic complementation demonstrates a regulatory role for myosin VIIa in actin dynamics of stereocilia.;Prosser Haydn M, Rzadzinska Agnieszka K, Steel Karen P, Bradley Allan, ;2008;Molecular and cellular biology;28;1702-12; 18160714
  • Multi-isotope imaging mass spectrometry reveals slow protein turnover in hair-cell stereocilia.;Zhang Duan-Sun, Piazza Valeria, Perrin Benjamin J, Rzadzinska Agnieszka K, Poczatek J Collin, Wang Mei, Prosser Haydn M, Ervasti James M, Corey David P, Lechene Claude P, ;2012;Nature;481;520-4; 22246323
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreUniversity of Veterinary Medicine, Vienna, Austria

Disease and phenotype information

IMPC phenotypes (gene matching)
  • increased mean corpuscular volume / IMPC
  • thrombocytopenia / IMPC
  • increased circulating HDL cholesterol level / IMPC
  • decreased erythrocyte cell number / IMPC
  • abnormal gait / IMPC
MGI phenotypes (gene matching)
  • decreased hematocrit / MGI
  • increased leukocyte cell number / MGI
  • increased neutrophil cell number / MGI
  • abnormal small intestine morphology / MGI
  • abnormal liver morphology / MGI
  • abnormal branching of the mammary ductal tree / MGI
  • enlarged spleen / MGI
  • spleen hyperplasia / MGI
  • enlarged lymph nodes / MGI
  • tremors / MGI
  • convulsive seizures / MGI
  • abnormal lung morphology / MGI
  • decreased body weight / MGI
  • decreased anxiety-related response / MGI
  • ataxia / MGI
  • hypoactivity / MGI
  • impaired coordination / MGI
  • abnormal gait / MGI
  • short stride length / MGI
  • decreased exploration in new environment / MGI
  • limb grasping / MGI
  • abnormal motor coordination/balance / MGI
  • abnormal hematopoietic system physiology / MGI
  • hyperglycemia / MGI
  • anemia / MGI
  • cardiac hypertrophy / MGI
  • increased mammary adenocarcinoma incidence / MGI
  • abnormal reflex / MGI
  • seizures / MGI
  • abnormal motor capabilities/coordination/movement / MGI
  • premature death / MGI
  • abnormal definitive hematopoiesis / MGI
  • abnormal brain morphology / MGI
  • no abnormal phenotype detected / MGI
  • neurodegeneration / MGI
  • abnormal spleen white pulp morphology / MGI
  • abnormal hematopoietic system morphology/development / MGI
  • abnormal megakaryocyte progenitor cell morphology / MGI
  • hepatic steatosis / MGI
  • decreased vertical activity / MGI
  • increased heart weight / MGI
  • increased systemic arterial blood pressure / MGI
  • albuminuria / MGI
  • decreased erythrocyte cell number / MGI
  • increased urine protein level / MGI
  • impaired social transmission of food preference / MGI
  • no phenotypic analysis / MGI
  • phenotypic reversion / MGI
  • abnormal dopaminergic neuron morphology / MGI
  • astrocytosis / MGI
  • abnormal depression-related behavior / MGI
  • decreased tumor growth/size / MGI
  • abnormal nervous system morphology / MGI
  • abnormal cardiac muscle relaxation / MGI
  • neuronal intranuclear inclusions / MGI
  • abnormal myocardial fiber physiology / MGI
  • abnormal Paneth cell morphology / MGI
  • decreased B cell number / MGI
  • decreased cardiac muscle contractility / MGI
  • glomerulosclerosis / MGI
  • abnormal podocyte morphology / MGI
  • muscle phenotype / MGI
  • homeostasis/metabolism phenotype / MGI
  • endocrine/exocrine gland phenotype / MGI
  • behavior/neurological phenotype / MGI
  • immune system phenotype / MGI
  • taste/olfaction phenotype / MGI
  • hematopoietic system phenotype / MGI
  • jerky movement / MGI
  • thrombocytosis / MGI
  • decreased ventricle muscle contractility / MGI
  • decreased mean corpuscular hemoglobin concentration / MGI
  • decreased dopamine level / MGI
  • abnormal podocyte slit diaphragm morphology / MGI
  • absent podocyte slit diaphragm / MGI
  • podocyte foot process effacement / MGI
  • increased megakaryocyte cell number / MGI
  • abnormal spatial reference memory / MGI
  • abnormal spatial working memory / MGI
  • abnormal splenic cell ratio / MGI
  • abnormal physiological response to xenobiotic / MGI
  • abnormal enterocyte proliferation / MGI
  • abnormal enterocyte apoptosis / MGI
  • abnormal neuron differentiation / MGI
  • increased mammary gland tumor incidence / MGI
  • myeloid hyperplasia / MGI
  • expanded mesangial matrix / MGI
  • mesangial cell hyperplasia / MGI
  • abnormal habituation to a new environment / MGI
  • abnormal ceramide level / MGI
  • decreased brain choline acetyltransferase activity / MGI
  • decreased brain tyrosine 3-monooxygenase activity / MGI
  • decreased vascular endothelial cell proliferation / MGI

Literature references

  • Mosaic complementation demonstrates a regulatory role for myosin VIIa in actin dynamics of stereocilia.;Prosser Haydn M, Rzadzinska Agnieszka K, Steel Karen P, Bradley Allan, ;2008;Molecular and cellular biology;28;1702-12; 18160714
  • Multi-isotope imaging mass spectrometry reveals slow protein turnover in hair-cell stereocilia.;Zhang Duan-Sun, Piazza Valeria, Perrin Benjamin J, Rzadzinska Agnieszka K, Poczatek J Collin, Wang Mei, Prosser Haydn M, Ervasti James M, Corey David P, Lechene Claude P, ;2012;Nature;481;520-4; 22246323

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).